rare diseases

Recursion Pharmaceuticals $121 million Series C for AI drug discovery

Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors.

The funds will be invested to continue building Recursion's AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology.

Rare Disease Day: UK aims to lead world in genomic healthcare
The UK government has announced a new National Genomic Healthcare Strategy which sets out how the UK can become the global leader in genomic healthcare.
Alex Guest Thu, 28/02/2019 - 11:27
Global collaboration publishes recommendations to speed rare disease diagnosis
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
Alex Guest Wed, 20/02/2019 - 16:59